@article{524dc64138224e1da5046395efe60a7b,
title = "The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer",
author = "Boughey, \{Judy C.\} and Blair, \{Sarah L.\} and Subhedar, \{Preeti D.\} and Edge, \{Stephen B.\} and White, \{Julia R.\} and Hunt, \{Kelly K.\}",
note = "Funding Information: Kelly K. Hunt is a member of the Medical Advisory Board for Armada Health and AstraZeneca, and has received research funding, paid to her institution, from Cairn Surgical, Eli Lilly \& Co., and Lumicell. Judy C. Boughey has received research funding from Cairns Surgical, PER, PeerView and Up-to-Date and research funding paid to her institution from Eli Lilly \& Co. Sarah L. Blair, Preeti D. Subhedar, Stephen B. Edge, and Julia White have no disclosures to declare. ",
year = "2022",
month = aug,
doi = "10.1245/s10434-022-11899-1",
language = "English (US)",
volume = "29",
pages = "4663--4666",
journal = "Annals of surgical oncology",
issn = "1068-9265",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "8",
}